SCHEMBL6933206

SCHEMBL6933206

Cc1ccc(C(=O)Nc2nc3ccccc3n2CC(C)N)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.71
MEN1 O00255 6/20 0.71
KMT2A Q03164 6/20 0.71
TSHR P16473 5/20 0.71
HPGD P15428 4/20 0.71
HSD17B10 Q99714 3/20 0.71
HTT P42858 2/20 0.71
SMN1; SMN2 Q16637 2/20 0.71
RAB9A P51151 5/20 0.69
NPC1 O15118 3/20 0.69
RXFP1 Q9HBX9 2/20 0.69
OPRK1 P41145 3/20 0.65
USP2 O75604 3/20 0.65
TP53 P04637 3/20 0.65
MAPK1 P28482 1/20 0.65
OPRM1 P35372 1/20 0.65
OPRD1 P41143 1/20 0.65
NPSR1 Q6W5P4 5/20 0.61
TDP1 Q9NUW8 1/20 0.61
ALDH1A1 P00352 4/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL6932652 0.83 KDM4E (0.79) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL6932648 0.81 KDM4E (0.82) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL6932644 0.77 KDM4E (0.58) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL11702089 0.75 RAB9A (0.64) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL11702096 0.73 RAB9A (0.65) KDM4EMEN1KMT2ATSHRHPGD
Dimethylamine SCHEMBL6930444 0.73 KDM4E (0.92) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL3604861 0.73 IRAK4 (0.80) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL11703846 0.72 KDM4E (1.00) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL18271764 0.72 HDAC6 (0.66) KDM4EMEN1KMT2ATSHRHPGD
SCHEMBL16201551 0.72 PDE11A (0.84) KDM4EMEN1KMT2ATSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6660870-B1 Serotonergic compounds which possess agonist activity at 5-HT2 receptors effectively lower and control normal and elevated IOP and are useful for treating glaucoma ALCON, INC. (CH) 2003-12-09 US claimed
WO-2001070705-A1 2-ACYLAMINOBENZIMIDAZOLE DERIVATIVES FOR TREATING GLAUCOMA ALCON, INC. (CH) 2001-09-27 WO claimed
US-6660870-B1 Serotonergic compounds which possess agonist activity at 5-HT2 receptors effectively lower and control normal and elevated IOP and are useful for treating glaucoma ALCON, INC. (CH) 2003-12-09 US disclosed
WO-2001070705-A1 2-ACYLAMINOBENZIMIDAZOLE DERIVATIVES FOR TREATING GLAUCOMA ALCON, INC. (CH) 2001-09-27 WO disclosed